Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

How SMSFs are staying ahead of the curve

Jessica Amir
September 30, 2020

Morning Bell 30 September

Jessica Amir
September 30, 2020

Morning Bell 29 September

Jessica Amir
September 29, 2020

Morning Bell 28 September

Jessica Amir
September 28, 2020

Weekly Wrap 25 September

Jessica Amir
September 25, 2020

Morning Bell 25 September

Jessica Amir
September 25, 2020

Morning Bell 24 September

Jessica Amir
September 24, 2020

Morning Bell 23 September

Jessica Amir
September 23, 2020

Morning Bell 22 September

Jessica Amir
September 22, 2020

Morning Bell 21 September

Jessica Amir
September 21, 2020

Weekly Wrap 18 September

Jessica Amir
September 18, 2020